LEO 152020

DRUG2 trials

Sponsors

JW Pharmaceutical

Conditions

Cardiac RepolarisationCholinergic UrticariaHealthy Volunteers

Phase 1

A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy People

CompletedNCT05508776

JW PharmaceuticalCardiac Repolarisation, Healthy Volunteers

Start: 2022-09-16End: 2022-12-28Updated: 2024-04-22

Phase 2

Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria

CompletedNCT04853992

JW PharmaceuticalCholinergic Urticaria

Start: 2021-05-10End: 2022-07-11Updated: 2024-04-22

Related Papers

Targeting histamine receptor 4 in cholinergic urticaria with izuforant (LEO 152020): results from a phase IIa randomized double-blind placebo-controlled multicentre crossover trial

British Journal of Dermatology2024-02-018 citations